The platform allows scientists, patients, and investors to fund, develop, and co-own new drugs through biotech DAOs, addressing gaps in traditional scientific funding. BIO’s existing network comprises 7 BioDAOs on Ethereum, with plans to expand to Solana and other blockchains in Q1 2025.